Novo Nordisk names new senior principal clinical scientist

Novo Nordisk has announced the appointment of renowned diabetes specialist Professor Stephen Gough as its new senior principal clinical scientist.

He joins Novo Nordisk from the Oxford Centre for Diabetes Endocrinology and Metabolism, where he led active diabetes research groups, with a focus on the genetics of autoimmunity, and aided the creation of new therapies.

In his new role, Professor Gough will be responsible for providing clinical guidance on the development of new molecules and drugs, from early stages through to phase III and beyond, for obesity and diabetes.

He will remain as a visiting professor of diabetes and fellow of Harris Manchester College at Oxford University following this appointment.

Alan Moses, chief medical officer of Novo Nordisk, said: "With his key clinical expertise, his experience as a researcher focused on patient issues and his compassion for patients with diabetes, Professor Gough will have a vital role in working toward Novo Nordisk's ambition of changing diabetes."

The company has more than 90 years of experience in developing new diabetes therapies, with the disease representing one of its key focus areas.